146 related articles for article (PubMed ID: 34391213)
1. Detection of recombinant erythropoietin biosimilar Jimaixin™ after administration in healthy subjects.
Martin L; Kafi R; Zhou X; Zhang L; Ericsson M; Marchand A
Drug Test Anal; 2022 Jan; 14(1):72-79. PubMed ID: 34391213
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of erythropoietin biosimilars Epotin™, Hemax® and Jimaixin™ by electrophoretic methods used for doping control analysis and specific N-glycan analysis revealed structural differences from original epoetin alfa drug Eprex®.
Capdeville P; Martin L; Cholet S; Damont A; Audran M; Ericsson M; Fenaille F; Marchand A
J Pharm Biomed Anal; 2021 Feb; 194():113750. PubMed ID: 33234415
[TBL] [Abstract][Full Text] [Related]
3. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.
Okano M; Sato M; Kaneko E; Kageyama S
Drug Test Anal; 2011; 3(11-12):798-805. PubMed ID: 22012825
[TBL] [Abstract][Full Text] [Related]
4. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.
Dehnes Y; Hemmersbach P
Drug Test Anal; 2011 May; 3(5):291-9. PubMed ID: 21387570
[TBL] [Abstract][Full Text] [Related]
5. An optimized SDS-PAGE protocol with a new blotting system for the initial testing procedure of ESAs in doping control.
Martin L; Martin JA; Audran M; Marchand A
Drug Test Anal; 2022 Jan; 14(1):181-187. PubMed ID: 33269539
[TBL] [Abstract][Full Text] [Related]
6. Improved detection methods significantly increase the detection window for EPO microdoses.
Martin L; Martin JA; Collot D; Hoang O; Audran M; Ericsson M; Marchand A
Drug Test Anal; 2021 Jan; 13(1):101-112. PubMed ID: 32737925
[TBL] [Abstract][Full Text] [Related]
7. Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol.
Reichel C; Erceg D; Lorenc B; Scheiblhofer V; Farmer L; Zanitzer K; Geisendorfer T; Gmeiner G; Thevis M
Drug Test Anal; 2023 Feb; 15(2):163-172. PubMed ID: 33450134
[TBL] [Abstract][Full Text] [Related]
8. Hyperhydration Effect on Pharmacokinetic Parameters and Detection Sensitivity of Recombinant Human Erythropoietin in Urine and Serum Doping Control Analysis of Males.
Athanasiadou I; Dokoumetzidis A; Voss SC; El Saftawy W; Al-Maadheed M; Valsami G; Georgakopoulos C
J Pharm Sci; 2019 Jun; 108(6):2162-2172. PubMed ID: 30684541
[TBL] [Abstract][Full Text] [Related]
9. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control.
Reichel C; Kulovics R; Jordan V; Watzinger M; Geisendorfer T
Drug Test Anal; 2009 Jan; 1(1):43-50. PubMed ID: 20355158
[TBL] [Abstract][Full Text] [Related]
10. New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration.
Martin L; Ashenden M; Bejder J; Hoffmann M; Nordsborg N; Karstoft K; Morkeberg J; Sharpe K; Lasne F; Marchand A
Drug Test Anal; 2016 Nov; 8(11-12):1119-1130. PubMed ID: 27390252
[TBL] [Abstract][Full Text] [Related]
11. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.
Dehnes Y; Shalina A; Myrvold L
Drug Test Anal; 2013; 5(11-12):861-9. PubMed ID: 24190107
[TBL] [Abstract][Full Text] [Related]
12. Practicing IEF-PAGE of EPO: the impact of detergents and sample application methods on analytical performance in doping control.
Reichel C
Drug Test Anal; 2010; 2(11-12):603-19. PubMed ID: 21204292
[TBL] [Abstract][Full Text] [Related]
13. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.
Desharnais P; Naud JF; Ayotte C
Drug Test Anal; 2013; 5(11-12):870-6. PubMed ID: 23720238
[TBL] [Abstract][Full Text] [Related]
14. Dried blood spots for erythropoietin analysis: Detection of micro-doses, EPO c.577del variant and comparison with in-competition matching urine samples.
Heiland CE; Martin L; Zhou X; Zhang L; Ericsson M; Marchand A
Drug Test Anal; 2024 Jun; 16(6):650-654. PubMed ID: 37942506
[TBL] [Abstract][Full Text] [Related]
15. Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin.
Reichel C; Thevis M
Bioanalysis; 2013 Mar; 5(5):587-602. PubMed ID: 23425274
[TBL] [Abstract][Full Text] [Related]
16. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE.
Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G
Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control.
Reichel C; Benetka W; Lorenc B; Thevis M
Drug Test Anal; 2016 Nov; 8(11-12):1131-1137. PubMed ID: 27552163
[TBL] [Abstract][Full Text] [Related]
18. Detection of a nonerythropoietic erythropoietin, Neuro-EPO, in blood after intranasal administration in rat.
Martin L; Garcia Rodriguez JC; Audran M; Ericsson M; Maurice T; Marchand A
Drug Test Anal; 2020 Nov; 12(11-12):1605-1613. PubMed ID: 32856413
[TBL] [Abstract][Full Text] [Related]
19. Combined immuno-purification and detection of recombinant erythropoietins and activin receptor type II-Fc fusion proteins by isoelectric focusing for application in doping control.
Martin L; Audran M; Marchand A
Drug Test Anal; 2019 Jan; 11(1):168-172. PubMed ID: 30091846
[TBL] [Abstract][Full Text] [Related]
20. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels.
Kohler M; Ayotte C; Desharnais P; Flenker U; Lüdke S; Thevis M; Völker-Schänzer E; Schänzer W
Int J Sports Med; 2008 Jan; 29(1):1-6. PubMed ID: 18050057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
